Fate Therapeutics Inc (FATE) Stock: Soaring On Financing And EU Approval

Shares in Fate Therapeutics Inc (NASDAQ:FATE) have soared today, gaining over 10% and reaching as high as $3.18 during the session. Why is Fate Soaring...

Keep Reading →